Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 129

Sort by

Sort Order Select

Journal Articles

Nelarabine Is Active in Pediatric T/Myeloid Mixed Phenotype Acute Leukemia

Ryan J Summers, Hope L Mumme, Anjali Khanna, Manoj Bhasin, Tamara P. Miller, Sunil S Raikar

Blood (2024) 144 (Supplement 1): 5902.

https://doi.org/10.1182/blood-2024-205142

Published: 2024

Journal Articles

In Vivo barcoded CRISPR-Cas9 Screen Identifies Ncoa4- mediated Ferritinophagy As a Dependence in Tet2 -Deficient Haemopoiesis

Justin CT Loke, Geon Geon Kim, Meaghan Boileau, Thuy T.P. Nguyen, Marie E McConkey, Aidan P. Miller, Wesley Shin, Christopher B. Hergott, Maria Ericsson, Anja E.H. Nordstrom, Scott A Armstrong, Joseph D Mancias, Benjamin Levine Ebert

Blood (2024) 144 (Supplement 1): 188.

https://doi.org/10.1182/blood-2024-200955

Published: 2024

Journal Articles

Real-World Generalizability of Clinical Trial Cytomolecular Features By Race and Ethnicity in Pediatric Acute Myeloid Leukemia (AML)

Blood (2024) 144 (Supplement 1): 531.

https://doi.org/10.1182/blood-2024-198385

Published: 2024

Journal Articles

Loss of Negative Metabolic Feedback Drives TET2 Mutant Inflammation

Blood (2024) 144 (Supplement 1): 4060.

https://doi.org/10.1182/blood-2024-208145

Published: 2024

Journal Articles

Trial in Progress: Update on the TACL T2020-003 Randomized Phase 2 Trial to Improve Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL-2)

Blood (2024) 144 (Supplement 1): 2828.1.

https://doi.org/10.1182/blood-2024-201871

Published: 2024

Journal Articles

Association of Race, Ethnicity, and Social Deprivation on the Incidence and Severity of Adverse Events in Induction in Children with Acute Lymphoblastic Leukemia

Jason M Stevenson, Anjali Khanna, Ashleigh Hawk, Avery Morse, Oyin Alao, Katherine Jordan, Xu Ji, Heeju Sohn, Sharon M. Castellino, Tamara P. Miller

Blood (2024) 144 (Supplement 1): 5110.

https://doi.org/10.1182/blood-2024-205766

Published: 2024

Journal Articles

A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia

Amanda M Li, Catherine Aftandilian, Susan Colace, Sarah Fanizzi, Kelly Elizabeth Faulk, Erin M. Guest, Ammar Hayani, Richard Ho, Anjali Khanna, Kasey Leger, David McCall, Tamara P. Miller, Holly Pacenta, Troy Quigg, Jeremy D. Rubinstein, Deepa Bhojwani, Susan R Rheingold, Maureen M. O'Brien, Karen R Rabin

Blood (2024) 144 (Supplement 1): 4204.

https://doi.org/10.1182/blood-2024-209455

Published: 2024

Journal Articles

Acuity of Illness at Initial Presentation Mediates Early Mortality in Adolescent and Young Adult Leukemia

Tarun Jain, Xu Ji, Nicholas Degroote, Alexandra Himes, Cortland Coxhead, Rebecca Williamson Lewis, Anjali Khanna, Alexandra Cathcart, Tamara P. Miller, Kristie A. Blum, Keiko Tarquinio, Sharon M. Castellino

Blood (2024) 144 (Supplement 1): 2347.

https://doi.org/10.1182/blood-2024-209796

Published: 2024

Journal Articles

Role of CYB5R3 in Erythropoiesis-Associated Heme Biosynthesis

Fabliha Ahmed Chowdhury, Malini Sharma, Katherine C Wood, Megan P Miller, Shuai Yuan, Adam C Straub

Blood (2024) 144 (Supplement 1): 2471.

https://doi.org/10.1182/blood-2024-198248

Published: 2024

Journal Articles

Understanding the Associations between High-Dose Methotrexate Pharmacokinetics and the Risk of Adverse Events in Children and Adolescents with Down Syndrome Associated High-Risk Acute Lymphoblastic Leukemia

Kate D. Westmoreland, Zachary L Taylor, Tamara P. Miller, Ashley Chavana, Karen R Rabin, Austin L Brown, Melanie Brooke Bernhardt, Eric S. Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey

Blood (2024) 144 (Supplement 1): 1438.

https://doi.org/10.1182/blood-2024-211870

Published: 2024

Journal Articles

Comparative Effectiveness of Reinduction Approaches for Pediatric Relapsed Acute Myeloid Leukemia

Caitlin W. Elgarten, Regina M. Myers, Alix E. Seif, Yimei Li, Daniel J. Zheng, Naomi J Winick, Elaine Morgan, Rajen Mody, Arunkumar Modi, Tamara P. Miller, Kelly Maloney, Mallorie M. Heneghan, M. Monica Gramatges, Brian T. Fisher, Kelly D. Getz, Richard Aplenc

Blood (2023) 142 (Supplement 1): 551.

https://doi.org/10.1182/blood-2023-188044

Published: 2023

Journal Articles

Racial and Ethnic Differences in Acuity and Cumulative Frontline Organ Toxicity at the Time of Relapse in Pediatric Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 387.

https://doi.org/10.1182/blood-2023-180713

Published: 2023

Journal Articles

Establishing Real-World Data-Driven Response Criteria in Pediatric Acute Myeloid Leukemia

Richard Aplenc, Yimei Li, Julianne Ani, Caitlin W. Elgarten, Lisa D'Errico, Todd Cooper, E. Anders Kolb, Maria Monica Gramatges, Meret Henry, Tamara P. Miller, Rajen Mody, Elaine Morgan, Regina M. Myers, Jessica A. Pollard, Alix Seif, Brian T. Fisher, Kelly D. Getz

Blood (2023) 142 (Supplement 1): 726.

https://doi.org/10.1182/blood-2023-185647

Published: 2023

Journal Articles

Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2430.

https://doi.org/10.1182/blood-2023-189240

Published: 2023

Journal Articles

Association of Age with Acuity and Severity of Illness at Initial Presentation in Children, Adolescents, and Young Adults with Leukemia

Tarun Jain, Xu Ji, Nicholas Degroote, Alexandra Himes, Cortland Coxhead, Anjali Khanna, Alexandra Cathcart, Tamara P. Miller, Kristie A. Blum, Keiko Tarquinio, Ann C. Mertens, Sharon M. Castellino

Blood (2023) 142 (Supplement 1): 3769.

https://doi.org/10.1182/blood-2023-189967

Published: 2023

Journal Articles

Severe Adverse Events Associated with Concentrations of High Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia Patients

Tamara P. Miller, Nicholas P. DeGroote, Zachary Taylor, Lauren Pommert, Oluwafunbi Awoniyi, Sarah Board, Ngozi Ugboh, Vivek Joshi, Allison Weisnicht, Nicholas Ambrosino, Melanie Brooke Bernhardt, Eric S Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey

Blood (2022) 140 (Supplement 1): 2185–2186.

https://doi.org/10.1182/blood-2022-169741

Published: 2022

Journal Articles

Comparable Incidence Rates of Hematologic and Non-Hematologic Malignancies, Thrombotic Events, and Autoimmune Disorders in Unrelated Adult Donors Undergoing Bone Marrow Collection Versus Peripheral Blood Stem Cell Mobilization with Recombinant Human Granulocyte Colony-Stimulating Factor (rHuG-CSF): Results of the Donor Long-Term Follow-up Study By the National Marrow Donor Program (NMDP)

Heather E Stefanski, Stephanie Bo-Subait, Hati Kobusingye, Deborah Mattila, Michelle Kuxhausen, Jennifer Schenfeld, Darcie Sandschafer, Cisio De Oliveira Brandao, Linda J Burns, Bronwen E. Shaw, Michael A. Pulsipher, John P Miller, Steven M Devine

Blood (2022) 140 (Supplement 1): 10862–10864.

https://doi.org/10.1182/blood-2022-159700

Published: 2022

Journal Articles

Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program

Heather E Stefanski, Jennifer Novakovich, Jennifer Newman, Christian Snyder, Meghann Cody, Jason Oakes, Amy Nielson, Jeffery Auletta, John P. Miller, Steven M Devine

Blood (2022) 140 (Supplement 1): 891–892.

https://doi.org/10.1182/blood-2022-168336

Published: 2022

Journal Articles

Preclinical Development and Screening of a Quinone-Nitroalkene Molecule for Sickle Cell Anemia

Fabliha A Chowdhury, Megan P Miller, Katherine C Wood, Malini Sharma, Shuai Yuan, Stefanie N Taiclet, Derek J Sinchar, Elizabeth R Rochon, Francisco J Schopfer, Bruce A Freeman, Adam C Straub

Blood (2022) 140 (Supplement 1): 957–958.

https://doi.org/10.1182/blood-2022-160188

Published: 2022

Journal Articles

Comparison of Severe Toxicities Following High Dose Methotrexate Administration By Demographics and over Time in Pediatric Patients with Acute Lymphoblastic Leukemia

Tamara P. Miller, Nicholas P. DeGroote, Lauren Pommert, Oluwafunbi Awoniyi, Sarah Board, Ngozi Ugboh, Vivek Joshi, Nicholas Ambrosino, Allison Weisnicht, Heidi Hsiao, Melanie Brooke Bernhardt, Eric S Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey

Blood (2021) 138 (Supplement 1): 1970.

https://doi.org/10.1182/blood-2021-151081

Published: 2021

NARROW

Nelarabine Is Active in Pediatric T/Myeloid Mixed Phenotype Acute Leukemia

In Vivo barcoded CRISPR-Cas9 Screen Identifies Ncoa4- mediated Ferritinophagy As a Dependence in Tet2 -Deficient Haemopoiesis

Real-World Generalizability of Clinical Trial Cytomolecular Features By Race and Ethnicity in Pediatric Acute Myeloid Leukemia (AML)

Loss of Negative Metabolic Feedback Drives TET2 Mutant Inflammation

Trial in Progress: Update on the TACL T2020-003 Randomized Phase 2 Trial to Improve Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL-2)

Association of Race, Ethnicity, and Social Deprivation on the Incidence and Severity of Adverse Events in Induction in Children with Acute Lymphoblastic Leukemia

A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia

Acuity of Illness at Initial Presentation Mediates Early Mortality in Adolescent and Young Adult Leukemia

Role of CYB5R3 in Erythropoiesis-Associated Heme Biosynthesis

Understanding the Associations between High-Dose Methotrexate Pharmacokinetics and the Risk of Adverse Events in Children and Adolescents with Down Syndrome Associated High-Risk Acute Lymphoblastic Leukemia

Comparative Effectiveness of Reinduction Approaches for Pediatric Relapsed Acute Myeloid Leukemia

Racial and Ethnic Differences in Acuity and Cumulative Frontline Organ Toxicity at the Time of Relapse in Pediatric Acute Myeloid Leukemia

Establishing Real-World Data-Driven Response Criteria in Pediatric Acute Myeloid Leukemia

Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia

Association of Age with Acuity and Severity of Illness at Initial Presentation in Children, Adolescents, and Young Adults with Leukemia

Severe Adverse Events Associated with Concentrations of High Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia Patients

Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program

Preclinical Development and Screening of a Quinone-Nitroalkene Molecule for Sickle Cell Anemia

Comparison of Severe Toxicities Following High Dose Methotrexate Administration By Demographics and over Time in Pediatric Patients with Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only